Simvastatin Dosing for Hypercholesterolemia and Cardiovascular Disease Prevention
The recommended starting dose of simvastatin is 20-40 mg once daily in the evening, with a maximum recommended dose of 40 mg daily for most patients. 1
Standard Dosing Algorithm
Initial Dosing
- Start with simvastatin 20-40 mg once daily for adults with hypercholesterolemia or cardiovascular disease risk 1
- Simvastatin 10 mg is classified as low-intensity therapy, reducing LDL-C by <30% 2
- Simvastatin 20-40 mg is classified as moderate-intensity therapy, reducing LDL-C by approximately 30-50% 2
Dose Titration
- Assess LDL-C as early as 4 weeks after initiating therapy and adjust dosage if necessary 1
- Most patients (72-93%) achieve target LDL-C levels on simvastatin 20 mg 3
- If LDL-C goals are not met with simvastatin 40 mg, switch to an alternative high-intensity statin rather than increasing simvastatin dose 1
Critical FDA Restriction on 80 mg Dose
The simvastatin 80 mg dose is restricted and should NOT be initiated in new patients due to increased myopathy risk. 1, 2
- Simvastatin 80 mg is only permitted in patients who have been taking this dose chronically (≥12 months) without evidence of muscle toxicity 1
- The FDA issued a safety announcement limiting use of simvastatin 80 mg because of increased myopathy and rhabdomyolysis risk 2
- For patients requiring high-intensity statin therapy, prescribe atorvastatin 40-80 mg or rosuvastatin 20-40 mg instead 4
Dosing Modifications for Specific Populations
Severe Renal Impairment
- For creatinine clearance 15-29 mL/min, start with simvastatin 5 mg once daily 1, 2
- No dosage adjustment needed for mild to moderate renal impairment 2
Drug Interactions Requiring Dose Reduction
The following concomitant medications require mandatory simvastatin dose limitations 1:
- Lomitapide: Reduce simvastatin dose by 50%; do not exceed 20 mg daily 1
- Verapamil, diltiazem, or dronedarone: Do not exceed 10 mg daily 1
- Amiodarone, amlodipine, or ranolazine: Do not exceed 20 mg daily 1
- Gemfibrozil or cyclosporine: Contraindicated with simvastatin 2, 1
Clinical Context-Specific Recommendations
Secondary Prevention (Established Cardiovascular Disease)
- Simvastatin is NOT the preferred statin for secondary prevention requiring high-intensity therapy 2
- High-intensity statins (atorvastatin 40-80 mg or rosuvastatin 20-40 mg) reduce cardiovascular events more than moderate-intensity therapy 2, 4
- If simvastatin is used, the maximum dose should be 40 mg daily 1
Primary Prevention
- Simvastatin 20-40 mg is appropriate for primary prevention in patients with 10-year cardiovascular risk ≥7.5% 2
- Low to moderate-intensity statins reduce all-cause mortality (RR 0.86), cardiovascular mortality (RR 0.69), and myocardial infarction (RR 0.64) 2
Diabetes with CKD
- In patients with diabetes and CKD stages 1-4, simvastatin 20 mg combined with ezetimibe 10 mg is an effective strategy to achieve LDL-C reduction while minimizing myopathy risk 2
- Higher doses of statins carry increased myopathy risk in patients with reduced kidney function 2
Common Pitfalls to Avoid
- Never initiate or titrate to simvastatin 80 mg due to FDA restrictions and myopathy risk 1, 2
- Do not use simvastatin when high-intensity statin therapy is indicated—switch to atorvastatin or rosuvastatin instead 4, 1
- Always check for drug interactions before prescribing, particularly with CYP3A4 inhibitors, calcium channel blockers, and fibrates 1, 2
- Adjust dose in severe renal impairment (CrCl <30 mL/min) to prevent myopathy 1, 2
- Monitor for muscle symptoms and obtain baseline and follow-up creatine kinase if clinically indicated 5